Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
703
-
Total 13F shares, excl. options
-
92.1M
-
Shares change
-
+867K
-
Total reported value, excl. options
-
$37.3B
-
Value change
-
+$424M
-
Put/Call ratio
-
0.92
-
Number of buys
-
421
-
Number of sells
-
-274
-
Price
-
$405.40
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q2 2020
803 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q2 2020.
DEXCOM INC - Common Stock (DXCM) has 703 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.1M shares
of 392M outstanding shares and own 23.52% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (10.3M shares), FMR LLC (8.63M shares), BlackRock Inc. (7.1M shares), BAILLIE GIFFORD & CO (4.54M shares), STATE STREET CORP (3.89M shares), MORGAN STANLEY (3.64M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.5M shares), JPMORGAN CHASE & CO (3.03M shares), JENNISON ASSOCIATES LLC (2.76M shares), and SANDS CAPITAL MANAGEMENT, LLC (1.84M shares).
This table shows the top 703 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.